199 related articles for article (PubMed ID: 30478410)
1. Blockade of muscarinic acetylcholine receptors facilitates motivated behaviour and rescues a model of antipsychotic-induced amotivation.
Hailwood JM; Heath CJ; Phillips BU; Robbins TW; Saksida LM; Bussey TJ
Neuropsychopharmacology; 2019 May; 44(6):1068-1075. PubMed ID: 30478410
[TBL] [Abstract][Full Text] [Related]
2. Effects of Muscarinic Acetylcholine m1 and m4 Receptor Blockade on Dyskinesia in the Hemi-Parkinsonian Rat.
Chambers NE; Meadows SM; Taylor A; Sheena E; Lanza K; Conti MM; Bishop C
Neuroscience; 2019 Jun; 409():180-194. PubMed ID: 31029732
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic M1, but not M4, receptor antagonism impairs divided attention in male rats.
Nicklas PR; Kiefer ML; Whalen MA; Stewart MT; Mosura DE; Bennett EM; Hawley WR; McLaughlin PJ
Pharmacol Biochem Behav; 2021 Jun; 205():173184. PubMed ID: 33836220
[TBL] [Abstract][Full Text] [Related]
4. Effects of biperiden (cholinergic muscarinic m1/m4 receptor antagonist) on ethanol conditioned place preference in mice.
Palombo P; Engi SA; Yokoyama TS; Bezerra AG; Curado DF; Anésio A; Leão RM; Santos PCJL; Cruz FC; Galduróz JCF
Neurosci Lett; 2021 Feb; 745():135551. PubMed ID: 33346074
[TBL] [Abstract][Full Text] [Related]
5. Rewarding effects of M4 but not M3 muscarinic cholinergic receptor antagonism in the rostromedial tegmental nucleus.
Buie N; Sodha D; Scheinman SB; Steidl S
Behav Brain Res; 2020 Feb; 379():112340. PubMed ID: 31697984
[TBL] [Abstract][Full Text] [Related]
6. Effects of muscarinic receptor antagonists on cocaine discrimination in wild-type mice and in muscarinic receptor M
Joseph L; Thomsen M
Behav Brain Res; 2017 Jun; 329():75-83. PubMed ID: 28442355
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M
J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457
[TBL] [Abstract][Full Text] [Related]
8. Selective M1 muscarinic receptor antagonists disrupt memory consolidation of inhibitory avoidance in rats.
Roldán G; Bolaños-Badillo E; González-Sánchez H; Quirarte GL; Prado-Alcalá RA
Neurosci Lett; 1997 Jul; 230(2):93-6. PubMed ID: 9259472
[TBL] [Abstract][Full Text] [Related]
9. Cholinergic gating of hippocampal auditory evoked potentials in freely moving rats.
Klinkenberg I; Sambeth A; Blokland A
Eur Neuropsychopharmacol; 2013 Aug; 23(8):988-97. PubMed ID: 22974558
[TBL] [Abstract][Full Text] [Related]
10. The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors.
Betz AJ; McLaughlin PJ; Burgos M; Weber SM; Salamone JD
Psychopharmacology (Berl); 2007 Oct; 194(3):347-59. PubMed ID: 17594079
[TBL] [Abstract][Full Text] [Related]
11. Cholinergic models of memory impairment in animals and man: scopolamine vs. biperiden.
Blokland A
Behav Pharmacol; 2022 Jun; 33(4):231-237. PubMed ID: 35621168
[TBL] [Abstract][Full Text] [Related]
12. The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide.
Veeraragavan S; Bui N; Perkins JR; Yuva-Paylor LA; Paylor R
Behav Neurosci; 2011 Oct; 125(5):783-90. PubMed ID: 21942438
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats.
Miyauchi M; Neugebauer NM; Sato T; Ardehali H; Meltzer HY
J Psychopharmacol; 2017 Dec; 31(12):1588-1604. PubMed ID: 28946779
[TBL] [Abstract][Full Text] [Related]
14. Loss of anti-cataleptic effect of scopolamine in mice lacking muscarinic acetylcholine receptor subtype 4.
Karasawa H; Taketo MM; Matsui M
Eur J Pharmacol; 2003 May; 468(1):15-9. PubMed ID: 12729838
[TBL] [Abstract][Full Text] [Related]
15. Modulation of prepulse inhibition through both M(1) and M (4) muscarinic receptors in mice.
Thomsen M; Wess J; Fulton BS; Fink-Jensen A; Caine SB
Psychopharmacology (Berl); 2010 Feb; 208(3):401-16. PubMed ID: 20013114
[TBL] [Abstract][Full Text] [Related]
16. Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats.
Brugnoli A; Pisanò CA; Morari M
Neurobiol Dis; 2020 Oct; 144():105044. PubMed ID: 32798726
[TBL] [Abstract][Full Text] [Related]
17. A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment.
Klinkenberg I; Blokland A
Psychopharmacology (Berl); 2011 Jun; 215(3):549-66. PubMed ID: 21336581
[TBL] [Abstract][Full Text] [Related]
18. Performance of conventional pigs and Göttingen miniature pigs in a spatial holeboard task: effects of the putative muscarinic cognition impairer Biperiden.
Gieling E; Wehkamp W; Willigenburg R; Nordquist RE; Ganderup NC; van der Staay FJ
Behav Brain Funct; 2013 Jan; 9():4. PubMed ID: 23305134
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor.
Fink-Jensen A; Schmidt LS; Dencker D; Schülein C; Wess J; Wörtwein G; Woldbye DP
Eur J Pharmacol; 2011 Apr; 656(1-3):39-44. PubMed ID: 21269601
[TBL] [Abstract][Full Text] [Related]
20. Alterations of M1 and M4 acetylcholine receptors in the genetically dystonic (dt
Hamann M; Plank J; Richter F; Bode C; Smiljanic S; Creed M; Nobrega JN; Richter A
Neuroscience; 2017 Aug; 357():84-98. PubMed ID: 28596119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
